Preview TAT 2016
Symposium President Giuseppe Giaccone gives a preview of TAT 2016 in Washington DC, March 21-23 2016: early-phase development of innovative targeted and immunological agents.
Near-final program available
The near-final program of TAT 2016 is online now. View the topics that will be covered at TAT 2016 and confirmed speakers’ names. Updated regularly!
Take advantage of our significantly reduced early registration fees until January 15, 2016. Register now and save USD 200 on your participation in one of the leading meetings on emerging innovations in systemic cancer therapy.
Exhibitor & Support Opportunities
Act now to identify the best strategies at TAT 2016 to get the RESULTS your company expects in this dynamic marketplace.
Abstracts on a wide range of topics in the field of targeted therapy for cancer are invited. Online abstract submission is open now until January 15, 2016.
Meet global phase 1 leaders
Expand your network with global leaders in early-phase drug development at TAT 2016. Many leading phase 1 investigators and translational research scientists are confirmed speakers or session chairs.